CIHIGH SIGNALFINANCIAL10-K

Cigna delivered exceptional 73.5% net income growth while dramatically shifting capital allocation from share buybacks to internal investments.

The massive earnings increase combined with doubled capital expenditures suggests strong business momentum and management's confidence in growth opportunities requiring significant investment. However, the 48.5% reduction in share buybacks may disappoint income-focused investors despite the strong operational performance.

Comparing 2026-02-26 vs 2025-02-27View on EDGAR →
FINANCIAL ANALYSIS

Cigna demonstrated robust financial performance with revenue growing 11.2% to $274.9B and net income surging 73.5% to $6.0B, indicating strong operational leverage and margin expansion. The company doubled capital expenditures to $1.1B while cutting share buybacks in half to $3.6B, signaling a strategic shift toward growth investments over immediate shareholder returns. This combination of exceptional earnings growth and increased investment spending suggests management is prioritizing long-term expansion opportunities over short-term capital returns.

FINANCIAL STATEMENT CHANGES
Capital Expenditure
Cash Flow
+98.9%
$528.0M→$1.1B

Capital expenditure jumped 98.9% — major investment cycle underway; assess returns on deployment.

Net Income
P&L
+73.5%
$3.4B→$6.0B

Net income grew 73.5% — bottom-line growth signals improving overall business health.

Share Buybacks
Cash Flow
-48.5%
$7.0B→$3.6B

Buyback activity reduced 48.5% — capital being redeployed elsewhere or cash conservation underway.

Revenue
P&L
+11.2%
$247.1B→$274.9B

Revenue growing 11.2% — solid top-line momentum, watch margins for quality of growth.

LANGUAGE CHANGES
NEW — 2026-02-26
PRIOR — 2025-02-27
ADDED
The aggregate market value of the voting stock held by non-affiliates of the registrant as of June 30, 2025 was approximately $ 88.0 billion.
As of January 30, 2026, 263,528,277 shares of the registrant's Common Stock were outstanding.
Management's Discussion and Analysis of Financial Condition and Results of Operations 36 Item 7A.
Powered by our dedicated people and valued brands, we advance our mission to improve the health and vitality of those we serve by staying grounded in the needs of our customers and patients - delivering a personalized, transparent and affordable health care experience.
We focus on leading the way to partner and innovate solutions for better health.
At The Cigna Group our global workforce of approximately 67,700 colleagues strives to fulfill our mission to improve the health and vitality of more than 185 million customer relationships in more than 30 markets and jurisdictions (as of December 31, 2025).
We play an important role in the health care system, and the breadth and depth of our customer relationships - as well as our approximately 1.7 million relationships with health care providers, clinics and facilities - give us opportunities to drive positive change.
We have two segments: Evernorth Health Services and Cigna Healthcare .
Cigna Healthcare, the health benefits segment of The Cigna Group, provides comprehensive medical and coordinated solutions to customers and clients served by our U.S.
Together, Evernorth Health Services and Cigna Healthcare combine pharmacy and medical capabilities to create solutions that improve affordability, transparency and health outcomes.
REMOVED
The aggregate market value of the voting stock held by non-affiliates of the registrant as of June 28, 2024 was approximately $ 92.1 billion.
As of January 31, 2025, 273,678,464 shares of the registrant's Common Stock were outstanding.
Management's Discussion and Analysis of Financial Condition and Results of Operations 38 Item 7A.
We relentlessly challenge ourselves to partner and innovate solutions for better health.
Powered by our people and our brands, we advance our mission to improve the health and vitality of those we serve.
Our Pathways to Growth To deliver differentiated value to our customers, patients, clients, communities and investors, we will continue to cultivate our portfolio of businesses to provide sustained foundational and accelerated growth through cross-enterprise leverage - today and in the future.
Our Differentiated Approach Clinical expertise and longitudinal data provide enhanced care and value.
Relentless focus on value and affordability improves the cost of care for our clients and customers.
Culture of innovation and partnership brings new services and capabilities to market.
At The Cigna Group, we relentlessly challenge ourselves to partner and innovate solutions for better health.
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →